Photo credit: www.sciencedaily.com
Cinnamon, a spice with ancient roots in culinary traditions, has emerged at the center of a significant health discussion due to recent research highlighting its potential interactions with certain prescription medications. A study conducted by the National Center for Natural Products Research at the University of Mississippi has shed light on a particular compound in cinnamon that may alter the metabolic processing of medications.
Published in the journal Food Chemistry: Molecular Sciences, the research draws attention to cinnamaldehyde, the primary active compound in cinnamon. The study indicates that this substance can activate specific receptors involved in the metabolic clearance of drugs. However, the findings suggest that excessive consumption of cinnamon might impair the efficacy of these medications.
Shabana Khan, a principal scientist at the center, warned of potential health risks, stating, “Health concerns could arise if excessive amounts of supplements are consumed without the knowledge of health care providers or the prescribers of the medications. Overconsumption could lead to a rapid clearance of prescription medicines, reducing their effectiveness.”
This spice is not just prized for its flavor; it has also been used in traditional medicine for its potential benefits in managing blood sugar levels, promoting heart health, and reducing inflammation. Nevertheless, the precise mechanisms by which cinnamon operates in the human body remain somewhat enigmatic.
While casually adding cinnamon to coffee is unlikely to pose a health risk, concentrated cinnamon supplements could lead to significant concerns. Khan emphasized the need for further understanding of cinnamaldehyde’s properties, particularly regarding its bioavailability and interactions with drug metabolism. “Understanding its bioaccessibility, metabolism, and interaction with xenobiotic receptors was critical for evaluating potential impacts on prescription drugs,” she noted.
It’s important to differentiate between types of cinnamon, according to Amar Chittiboyina, the center’s associate director. Cinnamon oil, often used for its antifungal and antibacterial properties, presents minimal risks of interaction with medications. In contrast, cinnamon bark, particularly the more affordable Cassia cinnamon variety from southern China, contains higher levels of coumarin—a substance known for its blood-thinning effects—compared to its Sri Lankan counterpart, often referred to as “true cinnamon.”
“True cinnamon, from Sri Lanka, has a lower coumarin content, which reduces the risk of complications for those taking anticoagulants,” Chittiboyina added, highlighting the potential dangers associated with high coumarin intake for individuals on blood-thinning medications.
Further investigation is warranted to clarify the implications of cinnamon consumption in relation to pharmaceuticals, as noted by Bill Gurley, another principal scientist involved in the study. “We understand that cinnamaldehyde may activate receptors that could lead to drug interaction risks, but definitive conclusions will require clinical studies,” he explained.
Until more comprehensive research is completed, experts advise those considering cinnamon supplements to consult healthcare professionals beforehand. “Individuals with chronic health conditions—such as hypertension, diabetes, cancer, arthritis, asthma, obesity, HIV, AIDS, or depression—should exercise caution when using cinnamon or any supplements,” Khan cautioned. “The safest approach is to discuss any supplement use with a healthcare provider prior to combining it with prescription medication.”
“It’s essential to remember that supplements are not designed to treat, cure, or alleviate any diseases,” she reiterated.
This research was supported, in part, by a cooperative agreement from the United States Department of Agriculture, emphasizing the ongoing interest in understanding the health implications of widely consumed natural products like cinnamon.
Source
www.sciencedaily.com